发明名称 |
Pharmaceutical composition for treating overactive bladder |
摘要 |
A pharmaceutical composition comprising (R)-2-(2-aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}acetanilide or a pharmaceutically acceptable salt thereof and (3R)-quinuclidin-3-yl (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a pharmaceutically acceptable salt thereof, as active ingredients, in particular for improving various symptoms accompanying overactive bladder, such as urinary urgency, pollakiuria and/or urinary incontinence. |
申请公布号 |
US8772315(B2) |
申请公布日期 |
2014.07.08 |
申请号 |
US201313748956 |
申请日期 |
2013.01.24 |
申请人 |
Astellas Pharma Inc. |
发明人 |
Suzuki Masanori;Ukai Masashi;Ohtake Akiyoshi |
分类号 |
A61K31/426 |
主分类号 |
A61K31/426 |
代理机构 |
Fitzpatrick, Cella, Harper & Scinto |
代理人 |
Fitzpatrick, Cella, Harper & Scinto |
主权项 |
1. A pharmaceutical composition, comprising: (i) (R)-2-(2-aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}acetanilide or a pharmaceutically acceptable salt thereof present from 25 to 50 mg in terms of (R)-2-(2-aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}acetanilide and (ii) (3R)-quinuclidin-3-yl (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a pharmaceutically acceptable salt thereof present at 5 mg in terms of (3R)-quinuclidin-3-yl (1S)-I-phenyl-I,2,3,4-tetrahydroisoquinoline-2-carboxylate succinate. |
地址 |
Tokyo JP |